Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
On this page:OverviewPublicationsResearchersInstitutionsOpen access
ScholarIQanswers from OpenAlex

Korea Pharma (South Korea)

InstitutionResearch output, impact & collaborations

Korea Pharma (South Korea) is a research organisation in Seoul, KR. OpenAlex records 1,265 works and 36,166 citations for it. 875 researchers list it as their most recent affiliation.

1,265
Works
36,166
Citations
875
Researchers
108.5
Avg h-index

How has Korea Pharma (South Korea)'s publication output changed over time?

ScholarIQpublication output · 2008–2023

Output grew0% over the shown period — from 1 works in 2008 to 1 in 2023.

1
1
1
1
2
2
1
2008201220132014201720202023

What are the most-cited papers on Korea Pharma (South Korea)?

ScholarIQmost cited works
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
Paul M. Ridker, Brendan M. Everett, Tom Thurén, Jean MacFadyen, William H. Chang, Christie M. Ballantyne, Francisco Antônio Helfenstein Fonseca, José Carlos Nicolau, Wolfgang Köenig, Stefan D. Anker, John J.P. Kastelein, Jan H. Cornel, Prem Pais, Daniel Pella, Jacques Genest, Renata Cífková, Alberto Lorenzatti, Tamás Forster, Zhanna Kobalava, L Vida-Simiti, Marcus Flather, Hiroaki Shimokawa, Hisao Ogawa, Mikael Dellborg, Paulo R.F. Rossi, Roland P.T. Troquay, Peter Libby, Robert J. Glynn
New England Journal of Medicine. 20179,298 CitationsOPEN ACCESS
Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol
Kausik K. Ray, R. Scott Wright, David Kallend, Wolfgang Köenig, Lawrence A. Leiter, Frederick J. Raal, Jenna A. Bisch, Tara Richardson, Mark Jaros, Peter Wijngaard, John J.P. Kastelein
New England Journal of Medicine. 20201,601 CitationsOPEN ACCESS
Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
John J.P. Kastelein, Fatima Akdim, Erik S.G. Stroes, Aeilko H. Zwinderman, Michiel L. Bots, Anton F. H. Stalenhoef, Frank L.J. Visseren, Eric J.G. Sijbrands, Mieke D. Trip, Evan A. Stein, Daniel Gaudet, Raphaël Duivenvoorden, Enrico P. Veltri, Adéle Marais, Eric de Groot
New England Journal of Medicine. 20081,243 CitationsOPEN ACCESS
Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk
Stephen J. Nicholls, A. Michael Lincoff, Michelle Garcia, Dianna Bash, Christie M. Ballantyne, Philip J. Barter, Michael H. Davidson, John J.P. Kastelein, Wolfgang Köenig, Darren K. McGuire, Dariush Mozaffarian, Paul M. Ridker, Kausik K. Ray, Brian G. Katona, Anders Himmelmänn, Larrye E. Loss, Martin Rensfeldt, Torbjörn Lundström, Rahul Agrawal, Venu Menon, Kathy Wolski, Steven E. Nissen
JAMA. 20201,002 CitationsOPEN ACCESS
Bempedoic Acid and Cardiovascular Outcomes in Statin-Intolerant Patients
Steven E. Nissen, A. Michael Lincoff, Danielle M. Brennan, Kausik K. Ray, Denise Mason, John J.P. Kastelein, Paul D. Thompson, Peter Libby, Leslie Cho, Jorge Plutzky, Harold Bays, Patrick M. Moriarty, Venu Menon, Diederick E. Grobbee, Michael J. Louie, Chien‐Feng Chen, Na Li, LeAnne T. Bloedon, Paula Robinson, Maggie Horner, William J. Sasiela, Jackie McCluskey, Deborah Davey, Pedro Fajardo-Campos, Predrag Petrović, Ján Fedačko, Witold Żmuda, Yury Lukyanov, Stephen J. Nicholls
New England Journal of Medicine. 2023906 CitationsOPEN ACCESS

How much of the research on Korea Pharma (South Korea) is open access?

ScholarIQopen access share
78%OPEN ACCESS
Gold
0%
Green
11%
Hybrid
0%
Bronze
67%
Closed
22%

Related on ScholarIQ

Gut microbiota and health
Top Topic
Probiotics and Fermented Foods
Top Topic
Skin Protection and Aging
Top Topic
Diabetes Treatment and Management
Top Topic
RNA Interference and Gene Delivery
Top Topic
Diabetes, Cardiovascular Risks, and Lipoproteins
Top Topic
470M+ articles · free account